{"id":413,"date":"2015-03-09T17:33:23","date_gmt":"2015-03-09T21:33:23","guid":{"rendered":"http:\/\/www.ipoboutique.com\/blog\/?p=413"},"modified":"2015-03-09T23:45:32","modified_gmt":"2015-03-10T03:45:32","slug":"secondaries-announced-3-9-2015","status":"publish","type":"post","link":"https:\/\/www.ipoboutique.com\/blog\/secondaries-announced-3-9-2015\/","title":{"rendered":"Secondaries announced 3.9.2015"},"content":{"rendered":"

IPOBoutique.Com rates secondary offerings to hit the tape with a \u2018BUY\u2019, \u2018NEUTRAL\u2019 or \u2018AVOID\u2019 rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary\u2019s he\u2019s issued with a \u2018BUY\u2019 rating.<\/p>\n

Company: CyberArk Software, Ltd.<\/strong>
\nSymbol: CYBR
\nPrice: Last trade $59.78
\nTrade Date: 3\/12
\nShares: 4 million
\nUnderwriter(s) Goldman Sachs, Deutsche Bank Securities, Barclays, BofA Merrill Lynch
\nCo Manager(s) William Blair, Nomura, Oppenheimer & Co.
\nRating=Subscription Needed<\/a><\/p>\n

Company: West Corporation<\/strong>
\nSymbol: WSTC
\nPrice: Last trade $34.74
\nTrade Date: 3\/13
\nShares: 11 million
\nUnderwriter(s) Goldman Sachs, Morgan Stanley, BofA Merrill Lynch, Barclays, Citigroup, Deutsche Bank, Wells Fargo
\nRating=Subscription Needed<\/a><\/p>\n

Company: Imperva Inc.<\/strong>
\nSymbol: IMPV
\nPrice: Last trade $45.44
\nTrade Date: 3\/13
\nShares: 3 million
\nUnderwriter(s) Morgan Stanley, Deutsche Bank, RBC Capital Markets, Pacific Crest Securities
\nCo Manager(s) Macquarie Capital, Nomura Securities International
\nRating=Subscription Needed<\/a><\/p>\n

Company: Calumet Specialty Products<\/strong>
\nSymbol: CLMT
\nPrice: Last trade $27.84
\nTrade Date: 3\/10
\nShares: 6 million
\nUnderwriter(s) Barclays Capital, Wells Fargo, BofA Merrill Lynch, J.P. Morgan, RBC Capital Markets
\nCo Manager(s) Credit Suisse, Deutsche Bank, Raymond James, Scotia Howard Weil
\nRating=Subscription Needed<\/a><\/p>\n

Company: Enbridge Energy<\/strong>
\nSymbol: EEP
\nPrice: Last trade $37.93
\nTrade Date: 3\/10
\nShares: 8 million
\nUnderwriter(s) Barclays, Citigroup, J.P. Morgan, Morgan Stanley
\nRating=Subscription Needed<\/a><\/p>\n

Company: Callon Petroleum<\/strong>
\nSymbol: CPE
\nPrice: Last trade $7.04
\nTrade Date: 3\/11
\nShares: 9 million
\nUnderwriter(s) J.P. Morgan
\nRating=Subscription Needed<\/a><\/p>\n

Company: Portola Pharmaceuticals, Inc.<\/strong>
\nSymbol: PTLA
\nPrice: Last trade $42.31
\nTrade Date: 3\/10
\nShares: 2.4 million
\nUnderwriter(s) Morgan Stanley
\nRating=Subscription Needed<\/a><\/p>\n

Company: Rosetta Resources Inc.<\/strong>
\nSymbol: ROSE
\nPrice: Last trade $17.96
\nTrade Date: 3\/10
\nShares: 12 million
\nUnderwriter(s) Morgan Stanley
\nRating=Subscription Needed<\/a><\/p>\n

Company: Gladstone Investment<\/strong>
\nSymbol: GAIN
\nPrice: Last trade $7.60
\nTrade Date: 3\/10
\nShares: 3 million
\nUnderwriter(s) Janney Montgomery Scott, Ladenburg Thalmann, Wunderlich Securities
\nCo Manager(s) J.J.B. Hilliard, W.L. Lyons, Maxim Group
\nRating=Subscription Needed<\/a><\/p>\n

Company: Main Street Capital Corporation<\/strong>
\nSymbol: MAIN
\nPrice: Last trade $31.14
\nTrade Date: 3\/10
\nShares: 2.4 million
\nUnderwriter(s) Raymond James, Baird, RBC Captial Markets
\nCo Manager(s) Sanders Morris Harris
\nRating=Subscription Needed<\/a><\/p>\n

Company: Zayo Group Holdings, Inc.<\/strong>
\nSymbol: ZAYO
\nPrice: Last trade $26.29
\nTrade Date: 3\/12
\nShares: 16 million
\nUnderwriter(s) Goldman Sachs, Barclays, Morgan Stanley, RBC Capital markets, J.P. Morgan, Citigroup, SunTrust Robinson Humphrey
\nRating=Subscription Needed<\/a><\/p>\n

Company: Tetraphase Pharmaceuticals<\/strong>
\nSymbol: TTPH
\nPrice: Last trade $36.00
\nTrade Date: 3\/12
\nShares: 3.5 million
\nUnderwriter(s) BMO Capital Markets, Stifel, Guggenheim Securities
\nCo Manager(s) Nomura, SunTrust Robinson Humphrey
\nRating=Subscription Needed<\/a><\/p>\n

Company: Pinnacle Foods Inc.<\/strong>
\nSymbol: PF
\nPrice: Last trade $37.01
\nTrade Date: 3\/10
\nShares: 14.3 million
\nUnderwriter(s) Credit Suisse
\nRating=Subscription Needed<\/a>
\nCompany: Kythera Biopharmaceuticals, Inc.<\/strong>
\nSymbol: KYTH
\nPrice: Last trade $51.17
\nTrade Date: 3\/11
\nShares: 2.4 million
\nUnderwriter(s) Goldman Sachs, Merrill Lynch, Pierce, Fenner & Smith
\nCo Manager(s) Cowen & Co.
\nRating=Subscription Needed<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

IPOBoutique.Com rates secondary offerings to hit the tape with a \u2018BUY\u2019, \u2018NEUTRAL\u2019 or \u2018AVOID\u2019 rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary\u2019s he\u2019s issued with a \u2018BUY\u2019 rating. Company: CyberArk Software, Ltd. Symbol: CYBR Price: Last trade $59.78 Trade Date: 3\/12 Shares: 4 million Underwriter(s) Goldman Sachs, Deutsche Bank Securities,[…]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":"","zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":"","zakra_breadcrumbs_separator_color":"","zakra_breadcrumbs_link_color":"","zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[35],"tags":[199,197,202,198,194,200,203,193,196,195,192,201,191],"class_list":["post-413","post","type-post","status-publish","format-standard","hentry","category-secondary-offerings","tag-clmt","tag-cpe","tag-cybr","tag-eep","tag-gain","tag-impv","tag-kyth","tag-main","tag-ptla","tag-rose","tag-ttph-pf","tag-wstc","tag-zayo"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/413","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=413"}],"version-history":[{"count":3,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/413\/revisions"}],"predecessor-version":[{"id":416,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/413\/revisions\/416"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=413"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=413"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=413"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}